BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15453958)

  • 61. Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging.
    Hayman JA; Callahan JW; Herschtal A; Everitt S; Binns DS; Hicks RJ; Mac Manus M
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):847-52. PubMed ID: 20472367
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparisons of
    Lee I; Byun BH; Lim I; Kim BI; Choi CW; Kim KM; Shin DY; Kang HJ; Lim SM
    Ann Nucl Med; 2019 Dec; 33(12):881-890. PubMed ID: 31571043
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Positron Emission Tomography Tracer 3'-Deoxy-3'-[18F]Fluorothymidine ([18F]FLT) Is Not Suitable to Detect Tissue Proliferation Induced by Systemic Yersinia enterocolitica Infection in Mice.
    Wiehr S; Rolle AM; Warnke P; Kohlhofer U; Quintanilla-Martinez L; Reischl G; Autenrieth IB; Pichler BJ; Autenrieth SE
    PLoS One; 2016; 11(10):e0164163. PubMed ID: 27701464
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 99mTc-depreotide tumour uptake in patients with non-Hodgkin's lymphoma.
    Bushnell DL; Menda Y; Madsen MT; Link BK; Kahn D; Truhlar SM; Juweid M; Shannon M; Murguia JS
    Nucl Med Commun; 2004 Aug; 25(8):839-43. PubMed ID: 15266180
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Early assessment of therapy response in malignant lymphoma with the thymidine analogue [18F]FLT.
    Buck AK; Kratochwil C; Glatting G; Juweid M; Bommer M; Tepsic D; Vogg AT; Mattfeldt T; Neumaier B; Möller P; Reske SN
    Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1775-82. PubMed ID: 17541585
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of 89Zr-rituximab tracer by Cerenkov luminescence imaging and correlation with PET in a humanized transgenic mouse model to image NHL.
    Natarajan A; Habte F; Liu H; Sathirachinda A; Hu X; Cheng Z; Nagamine CM; Gambhir SS
    Mol Imaging Biol; 2013 Aug; 15(4):468-75. PubMed ID: 23471750
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A simplified analysis of [18F]3'-deoxy-3'-fluorothymidine metabolism and retention.
    Shields AF; Briston DA; Chandupatla S; Douglas KA; Lawhorn-Crews J; Collins JM; Mangner TJ; Heilbrun LK; Muzik O
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1269-75. PubMed ID: 15991018
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma.
    Vail DM; Thamm DH; Reiser H; Ray AS; Wolfgang GH; Watkins WJ; Babusis D; Henne IN; Hawkins MJ; Kurzman ID; Jeraj R; Vanderhoek M; Plaza S; Anderson C; Wessel MA; Robat C; Lawrence J; Tumas DB
    Clin Cancer Res; 2009 May; 15(10):3503-10. PubMed ID: 19417014
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Exploring the applicability of a lesion segmentation method on [
    Pitarch G; Rotstein Habarnau Y; Chirico R; Konowalik B; Pérez A; Valda A; Bastianello M
    Eur J Hybrid Imaging; 2023 Dec; 7(1):28. PubMed ID: 38143262
    [TBL] [Abstract][Full Text] [Related]  

  • 70. F-18 FLT PET: a noninvasive diagnostic tool for visualization of the bone marrow compartment in patients with aplastic anemia: a pilot study.
    Agool A; Slart RH; Kluin PM; de Wolf JT; Dierckx RA; Vellenga E
    Clin Nucl Med; 2011 Apr; 36(4):286-9. PubMed ID: 21368602
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Pilot Study of 18F-FLT PET/CT in Pediatric Lymphoma.
    Costantini DL; Vali R; McQuattie S; Chan J; Punnett A; Weitzman S; Shammas A; Charron M
    Int J Mol Imaging; 2016; 2016():6045894. PubMed ID: 27313888
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Preclinical Evidence That 3'-Deoxy-3'-[18F]Fluorothymidine PET Can Visualize Recovery of Hematopoiesis after Gemcitabine Chemotherapy.
    Schelhaas S; Held A; Bäumer N; Viel T; Hermann S; Müller-Tidow C; Jacobs AH
    Cancer Res; 2016 Dec; 76(24):7089-7095. PubMed ID: 27923827
    [TBL] [Abstract][Full Text] [Related]  

  • 73.
    Tsujikawa T; Tasaki T; Hosono N; Mori T; Makino A; Kiyono Y; Zanotti-Fregonara P; Yamauchi T; Okazawa H
    EJNMMI Res; 2019 Feb; 9(1):16. PubMed ID: 30771115
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Targeted Therapy and Immunotherapy Response Assessment with F-18 Fluorothymidine Positron-Emission Tomography/Magnetic Resonance Imaging in Melanoma Brain Metastasis: A Pilot Study.
    Nguyen NC; Yee MK; Tuchayi AM; Kirkwood JM; Tawbi H; Mountz JM
    Front Oncol; 2018; 8():18. PubMed ID: 29520339
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A Novel Application of [18F]Fluorothymidine-PET ([18F]FLT-PET) in Clinical Practice to Quantify Regional Bone Marrow Function in a Patient With Treatment-Induced Cytopenias and to Guide "Marrow-Sparing" Radiotherapy.
    Campbell BA; Hofman MS; Prince HM
    Clin Nucl Med; 2019 Nov; 44(11):e624-e626. PubMed ID: 31584492
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Assessing Bone Marrow Activity with [
    Yassin MA; Nehmeh SA; Nashwan AJ; Kohla SA; Mohamed SF; Ismail OM; Al Sabbagh A; Soliman DS; Szabados L; Fayad H
    Technol Cancer Res Treat; 2022; 21():15330338221086396. PubMed ID: 35341409
    [No Abstract]   [Full Text] [Related]  

  • 77. Whole-Body Distribution of Leukemia and Functional Total Marrow Irradiation Based on FLT-PET and Dual-Energy CT.
    Magome T; Froelich J; Holtan SG; Takahashi Y; Verneris MR; Brown K; Dusenbery K; Wong J; Hui SK
    Mol Imaging; 2017; 16():1536012117732203. PubMed ID: 28948859
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Imaging of subclinical haemopoiesis after stem-cell transplantation in patients with haematological malignancies: a prospective pilot study.
    Williams KM; Holter-Chakrabarty J; Lindenberg L; Duong Q; Vesely SK; Nguyen CT; Havlicek JP; Kurdziel K; Gea-Banacloche J; Lin FI; Avila DN; Selby G; Kanakry CG; Li S; Scordino T; Adler S; Bollard CM; Choyke P; Gress RE
    Lancet Haematol; 2018 Jan; 5(1):e44-e52. PubMed ID: 29248669
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 18F-Fluorothymidine PET for Functional Response Assessment Following Radiation Therapy for Extramedullary Hematopoiesis.
    Campbell BA; Callahan J; Cole-Sinclair M; MacManus M; Hofman MS
    Clin Nucl Med; 2021 Sep; 46(9):e454-e457. PubMed ID: 33661206
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Exceptionally low metabolic activity in aggressive peripheral T-cell lymphoma.
    Tang B; Douglas-Nikitin V; Balon H; Wong CO; Khong PL; Wong CY
    Nucl Med Commun; 2009 Nov; 30(11):838-40. PubMed ID: 19734816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.